Download PDF
Journal of Pediatric Neurology 2021; 19(06): 443-445
DOI: 10.1055/s-0040-1722619
Case Report

PCDH12-Related Movement Disorder

Chaithanya Reddy
1   Department of Pediatrics, Pediatric Neurology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Pradip Paria
1   Department of Pediatrics, Pediatric Neurology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Singanamalla Bhanudeep
1   Department of Pediatrics, Pediatric Neurology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Vikas Bhatia
2   Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
Arushi G. Saini
1   Department of Pediatrics, Pediatric Neurology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Protocadherin 12 (PCDH12) is a member of a nonclustered group of cell surface proteins. Mutations in the PCDH12 gene can cause varied phenotypes ranging from epilepsy and movement disorders to congenital malformations and calcifications in neuroimaging. We discussed here a 14-year-old male patient with a movement disorder that mimicked dyskinetic cerebral palsy in the outpatient department; however, exome sequencing revealed a homozygous premature stop codon in exon 1 of the PCDH12(−) gene. The case highlights the importance of careful clinical examination to look for the features that do not match an assigned neurological syndrome and the need for follow-up neuroimaging to look for any progressive changes in all cases of unexplained movement disorder and intellectual impairment.

Keywords

protocadherin - PCDH12 - congenital - infection - movement disorder - dyskinetic cerebral palsy

Authors' Contributions

C.R., P.P., and S.B. prepared the initial draft of manuscript, reviewed the literature, and revised the manuscript for intellectual content. V.B. prepared the neuroimaging inputs and revised the manuscript for intellectual content. A.G.S. contributed in conceptualization, critical review of the manuscript, and edited the final version of manuscript. All the authors approve the manuscript for submission.




Publication History

Received: 11 October 2020

Accepted: 08 December 2020

Article published online:
17 February 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Aran A, Rosenfeld N, Jaron R. et al. Loss of function of PCDH12 underlies recessive microcephaly mimicking intrauterine infection. Neurology 2016; 86 (21) 2016-2024
    CrossrefPubMedGoogle Scholar
  • 2 Nicolas G, Sanchez-Contreras M, Ramos EM. et al. Brain calcifications and PCDH12 variants. Neurol Genet 2017; 3 (04) e166
    CrossrefPubMedGoogle Scholar
  • 3 Suzuki-Muromoto S, Wakusawa K, Miyabayashi T. et al. A case of new PCDH12 gene variants presented as dyskinetic cerebral palsy with epilepsy. J Hum Genet 2018; 63 (06) 749-753
    CrossrefPubMedGoogle Scholar
  • 4 Guemez-Gamboa A, Çağlayan AO, Stanley V. et al. Loss of protocadherin-12 leads to diencephalic-mesencephalic junction dysplasia syndrome. Ann Neurol 2018; 84 (05) 638-647
    CrossrefPubMedGoogle Scholar
  • 5 Keeler AB, Molumby MJ, Weiner JA. Protocadherins branch out: multiple roles in dendrite development. Cell Adhes Migr 2015; 9 (03) 214-226
    CrossrefPubMedGoogle Scholar
  • 6 Vineeth VS, Das Bhowmik A, Balakrishnan S, Dalal A, Aggarwal S. Homozygous PCDH12 variants result in phenotype of cerebellar ataxia, dystonia, retinopathy, and dysmorphism. J Hum Genet 2019; 64 (02) 183-189
    CrossrefPubMedGoogle Scholar